Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1: Design, Synthesis, and Preclinical Characterization
- 5 June 2004
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (14) , 3491-3494
- https://doi.org/10.1021/jm049766q
Abstract
Indole oxoacetic acid derivatives were prepared and evaluated for in vitro binding to and inactivation of human plasminogen activator inhibitor-1 (PAI-1). SAR based on biochemical, physiological, and pharmacokinetic attributes led to identification of tiplaxtinin as the optimal selective PAI-1 inhibitor. Tiplaxtinin exhibited in vivo oral efficacy in two different models of acute arterial thrombosis. The remarkable preclinical safety and metabolic stability profiles of tiplaxtinin led to advancing the compound to clinical trials.Keywords
This publication has 12 references indexed in Scilit:
- Intramural Plasminogen Activator Inhibitor Type-1 and Coronary AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Remodeling of the Vessel Wall after Copper-Induced Injury Is Highly Attenuated in Mice with a Total Deficiency of Plasminogen Activator Inhibitor-1The American Journal of Pathology, 2001
- Course of molecular hemostatic markers during and after different surgical proceduresJournal of Clinical Anesthesia, 1999
- Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosisBritish Journal of Pharmacology, 1998
- XR5118, a novel modulator of plasminogen activator inhibitor-1 (PAI-1), increases endogenous tPA activity in the ratFibrinolysis and Proteolysis, 1997
- Inhibitory Effect of a New Butadiene Derivative on the Production of Plasminogen Activator Inhibitor-1 in Cultured Bovine Endothelial CellsThe Journal of Biochemistry, 1996
- Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.Journal of Clinical Investigation, 1996
- The Acid Stabilization of Plasminogen Activator Inhibitor-1 Depends on Protonation of a Single Group That Affects Loop Insertion into β-Sheet AJournal of Biological Chemistry, 1995
- Thrombolysis and Reocclusion in Experimental Jugular Vein and Coronary Artery ThrombosisCirculation, 1995
- Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.Proceedings of the National Academy of Sciences, 1992